Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X

Clinical Chemistry

Volumn 60, Issue 1, 2014, Pages 243-250

  Rava, Richard P ^a   Srinivasan, Anupama ^a   Sehnert, Amy J ^a   Bianchi, Diana W ^b  

^a ILLUMINA INC   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; CELL FREE DNA; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; BLOOD SAMPLING; BODY MASS; CELL FRACTIONATION; CELL FREE SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ETHNICITY; FEMALE; FETAL FRACTION; FETUS; FETUS BLOOD; GESTATIONAL AGE; HUMAN; HUMAN GENOME; KARYOTYPE; MALE; MATERNAL BLOOD; MONOSOMY X; MULTICENTER STUDY; PARAMETERS; PREDICTIVE VALUE; PREGNANCY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; TRISOMY;

EID: 84891792588     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.207951     Document Type: Article

References (19)

1. American College of Obstetricians and Gynecologists. Committee opinion no. 545. Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120: 1532-4.
2. Fan HC, Quake SR. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010; 5:e10439.
3. Lo YM, Tein MS, Lau T, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genetics 1998;62: 768-75. (Pubitemid 28194317)
4. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
5. Ashoor G, Poon L, Syngelaki A, Mosimann B, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors. Fetal Diagn Ther 2012;31: 237-43.
6. Ashoor G, Syngelaki A, Poon LC, Rezende JC, Nicolaides KH. Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol 2013;41: 26-32.
7. Birch L, English CA, O'Donoghue K, Barigye O, Fisk NM, Keer JT. Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005;51: 312-20. (Pubitemid 40175800)
8. Nygren AOH, Dean J, Jensen TJ, Kruse S, Kwong W. Quantification of fetal DNA by use of methylation-based DNA discrimination. Clin Chem 2010;56: 1627-35.
9. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206: 319.e1-9.
10. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Erich M, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13: 913-20.
11. Jiang P, Chan KCA, Liao GJW, Zheng YWL, Leung TY, Chiu RWK, et al. FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma. Bioinformatics 2012;28: 2883-90.
12. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105: 16266-71.
13. Srinivasan A, Bianchi DW, Huang H, Sehnert AJ, Rava RP. Noninvasive detection of fetal subchromosome abnormalities using deep sequencing of maternal plasma. Am J Hum Genet 2013; 92: 167-76.
14. Bianchi DW, Platt LD, Goldberg JD, Abuhamad A, Sehnert AJ, Rava RP. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012;119: 890-901.
15. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57: 1042-9.
16. Futch T, Spinosa J, Bhatt S, de Feo E, Rava RP, Sehnert AJ. Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples. Prenat Diagn 2013;33: 569-74.
17. Mennuti MT, Cherry AM, Morrissette JJ, Dugoff L. Is it time to sound an alarm about falsepositive cell-free DNA testing for fetal aneuploidy? Am J Obstet Gynecol 2013;209: 415-9.
18. Hall AL, Drendel HM, Verbrugge JL, Reese AM, Schumacher KL, Griffith CB, et al. Positive cellfree fetal DNA testing for trisomy 13 reveals confined placental mosaicism. Genet Med 2013; 15: 729-32.
19. Choi H, Lau TK, Jiang FM, Chan MK, Zhang HY, Lo PS, et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'false positive' due to confined placental mosaicism. Prenat Diagn 2012;32: 1-3.